Tusk Therapeutics Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Tusk Therapeutics Ltd.
Despite a recent disappointment in a similar partnership with BioNTech, Genentech is pushing ahead with its neoantigen-targeting strategy.
- Large Molecule
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.